image
Viridian Therapeutics, Inc. VRDN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 14.72
-1.87 %
$ 1.2 B
Market Cap
-4.34
P/E
Price Target Average
158.15%
Revenue Forecast Estimate
657.17%
EBIT Estimate
--34.98%
Net Income Estimate
30.90%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Viridian Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for VRDN of $38 , with forecasts ranging from a low of $22 to a high of $56 .
VRDN Lowest Price Target Wall Street Target
22 USD 49.46%
VRDN Average Price Target Wall Street Target
38 USD 158.15%
VRDN Highest Price Target Wall Street Target
56 USD 280.43%
Price
Max Price Target
Min Price Target
Average Price Target
60605555505045454040353530302525202015151010Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart VRDN

image
$1.0b$1.0b$900.0m$900.0m$800.0m$800.0m$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart VRDN

image
$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)($700.0m)($700.0m)($800.0m)($800.0m)($900.0m)($900.0m)($1.0b)($1.0b)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart VRDN

image
$2.0b$2.0b$0.0$0.0($2.0b)($2.0b)($4.0b)($4.0b)($6.0b)($6.0b)($8.0b)($8.0b)($10.0b)($10.0b)($12.0b)($12.0b)($14.0b)($14.0b)($16.0b)($16.0b)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029